老年胰腺癌早期诊断及微创外科治疗的研究进展

doi:10.11904/j.issn.1002-3070.2023.03.010

Abstract

Abstract: In recent years,the incidence of pancreatic cancer has gradually increased,and the proportion of elderly pancreatic cancer has also gradually increased,Therefore,in clinical diagnosis and treatment,more attention should be paid to the diagnosis and treatment of pancreatic cancer in the elderly.However,clinical practice has found that the diagnosis and treatment of elderly pancreatic cancer is still insufficient,the most obvious is the low rate of early diagnosis,so the proportion of patients receiving radical surgery is low,leading to poor clinical efficacy and prognosis.Currently,there are many feasible methods for the diagnosis of pancreatic cancer,and minimally invasive surgery is an important choice for the clinical treatment of pancreatic cancer.This article discusses the status of early diagnosis and minimally invasive surgical treatment of elderly pancreatic cancer in order to provide a certain guidance for the diagnosis and treatment of pancreatic cancer in the elderly.

Key words: Elderly, Pancreatic cancer, Diagnosis, Minimally invasive surgery, Treatment

CLC Number:

R735.9

XU Ting, CHENG Hua, ZHANG Wei. Research progress in the early diagnosis and minimally invasive surgical treatment of elderly pancreatic cancer[J]. Journal of Practical Oncology, 2023, 37(3): 257-261.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2023.03.010

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2023/V37/I3/257

References

1 马翼飞,贺海蓉,晏天傲,等.1990—2019年中国、日本、韩国胰腺癌流行病学趋势及主要风险归因分析[J].中华消化外科杂志,2022,21(4):507-519.
2 Cai J,Chen H,Lu M,et al.Advances in the epidemiology of pancreatic cancer:Trends,risk factors,screening,and prognosis[J].Cancer Lett,2021,10(520):1-11.
3 蔡洁,陈宏达,卢明,等.2005-2015年中国胰腺癌发病与死亡趋势分析[J].中华流行病学杂志,2021,42(5):794-800.
4 Kanno A,Masamune A,Hanada K,et al.Multicenter study of early pancreatic cancer in Japan[J].Pancreatology,2018,18(1):61-67.
5 Kanno A,Masamune A,Hanada K,et al.Advances in early detection of pancreatic cancer[J].Diagnostics,2019,9(1):18.
6 吴丽权,郭文,李跃,等.内镜超声引导下细针抽吸术对胰腺导管腺癌的预测及诊断价值[J].南方医科大学学报,2018,38(10):1171-1178.
7 Kuruma S,Kikuyama M,Chiba K,et al.Carcinoma in situ of the pancreas with pancreatic duct stricture persistent for 4 years diagnosed by serial pancreatic juice aspiration cytologic examination(SPACE)[J].Clin J Gastroenterol,2020,13(3):443-447.
8 Ishikawa-Kakiya Y,Maruyama H,Kinoshita Y,et al.The usefulness of serial pancreatic juice aspiration cytological examination for pancreatic cancer not diagnosed by EUS-FNAB[J].Clin J Gastroenterol,2020,13(6):1367-1372.
9 Hanada K,Minami T,Shimizu A,et al.Roles of ERCP in the early diagnosis of pancreatic cancer[J].Diagnostics,2019,9(1):30.
10 Yamashita Y,Kitano M,Ashida R.Value of endoscopy for early diagnosis of pancreatic carcinoma[J].Dig Endosc,2020,32(1):27-36.
11 张灿,孙备.美国国立综合癌症网络临床实践指南:胰腺癌(2022.V1)更新解读[J].临床外科杂志,2023,31(1):7-10.
12 Yeh R,Dercle L,Garg I,et al.The Role of 18F-FDG PET/CT and PET/MRI in pancreatic ductal adenocarcinoma[J].Abdom Radiol,2018,43(2):415-434.
13 吴彪,弓健,程勇,等.对比18F-FDG PET/CT与PET/MRI诊断胰腺占位性病变[J].中国医学影像技术,2021,(11):1614-1618.
14 Liu X,Ren Y,Wang J,et al.The Clinical Diagnostic Value of F-FDG PET/CT Combined with MRI in Pancreatic Cancerp[J].Contrast Media Mol Imaging,2022,2022:1479416.
15 Nakamura S,Sadakari Y,Ohtsuka T,et al.Pancreatic juice exosomal microRNAs as biomarkers for detection of pancreatic ductal adenocarcinoma[J].Ann Surg Oncol,2019,26(7):2104-2111.
16 Tao L,Zhou J,Yuan C,et al.Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer[J].Metabolomics,2019,15(6):86-90.
17 郭怀斌,李凤飞,刘一璠,等.GPC-1外泌体、CD82外泌体和CA19-9用于胰腺癌诊断的病例对照研究[J].河北医科大学学报,2022,43(1):35-38.
18 Zhou Q,Andersson R,Hu D,et al.Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis[J].Transl Res,2019,212(20):67-79.
19 Xu X,Xiao Y,Hong B,et al.Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer[J].Cancer Biomark,2019,25(3):251-257.
20 Xu J,Liao K,Fu Z,et al.A new method for early detection of pancreatic cancer biomarkers:detection of micro RNAs by nanochannels[J].Artif Cells Nanomed Biotechnol,2019,47(1):2634-2640.
21 王勇.CA19-9联合K-ras基因突变检测对胰腺癌的诊断价值[J].西藏医药,2022,43(3):23-25.
22 梅晗,周辉,陈煜枫,等.外周血E-selectin、P-selection及K-ras基因突变水平在胰腺癌中的表达及意义[J].解放军医药杂志,2021,33(1):16-19,26.
23 田永,王瑞勤,常越,等.微小RNA-143、糖类抗原19-9在胰腺癌诊断和预后预测中的应用价值[J].癌症进展,2022,20(14):1505-1508.
24 刘允怡.腔镜下胰十二指肠切除微创手术在胰头癌的应用[J].中华腔镜外科杂志(电子版),2017,10(6):321-323.
25 Chapman BC,Gajdos C,Hosokawa P,et al.Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma[J].Surg Endosc,2018,32(5):2239-2248.
26 成功,阮一,王逻逻,等.高龄腹腔镜胰十二指肠切除术39例临床分析[J].现代实用医学,2022,34(3):296-298.
27 李红霞,东爱华.老年患者腹腔镜胰十二指肠切除术后胰瘘的危险因素分析[J].老年医学与保健,2022,28(3):488-492.
28 刘荣,赵国栋,唐文博,等.机器人胰腺手术 1010 例经验与教训[J].南方医科大学学报,2018,38(2):130-134.
29 Shyr YM,,Wang SE,Chen SC,et al.Robotic pancreaticoduodenectomy for pancreatic head cancer and periampullary lesions[J].Ann Gastroenterol Surg,2021,5(5):589-596.
30 党树伟,刘明,李广恩,等.Da Vinci Xi机器人胰十二指肠切除术(附5例报告)[J].腹腔镜外科杂志,2020,25(6):407-411.
31 Nassour I,Choti MA,Porembka MR,et al.Robotic-assisted versus laparoscopic pancreaticoduodenectomy:Oncological outcomes[J].Surg Endosc,2018,32(6):2907-2913.
32 代鑫,刘汉林,王强,等.达芬奇机器人与传统腹腔镜胰十二指肠切除术近期疗效及安全性比较的Meta分析[J].临床肝胆病杂志,2022,38(5):1106-1113.
33 Gavriilidis P,Roberts KJ,Sutcliffe RP.Laparoscopic versus open distal pancreatectomy for pancreatic adenocarcinoma:a systematic review and Meta-analysis[J].Acta Chir Belg,2018,118(5):278286.
34 Raoof M,Ituarte P,Woo Y,et al.Propensity score-matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection[J].Br J Surg,2018,105(5):578-586.
35 Larkins K,Rowcroft A,Pandanaboyana S,et al.A systematic scoping review of the initial experience with laparoscopic radical antegrade modular pancreatosplenectomy for pancreatic malignancy[J].Surg Endosc.2021,35(9):4930-4944.
36 Kantor O,Bryan DS,Talamonti MS,et al.Laparoscopic distal pancreatectomy for cancer provides oncologic outcomes and overall survival identical to open distal pancreatectomy[J].J Gastrointest Surg,2017,21(10):1620-1625.

[1]	CHEN Qi, HE Mingxv, JIA Keliang, MIAO Jianlong, HAN Liping. Research progress on the prognosis and treatment of non-small cell lung cancer with TP53-EGFR co-mutation [J]. Journal of Practical Oncology, 2023, 37(3): 262-266.
[2]	WEN Shichao, WANG Jingxuan. Research status of copper-dependent cell death and copper in breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 185-189.
[3]	SUN Xinglu, CHEN Che. Research progress of Egr1 in liver cancer [J]. Journal of Practical Oncology, 2022, 36(5): 435-439.
[4]	WANG Xinghan, LV Yalei. Mechanisms of trastuzumab resistance and post-resistance treatment strategies in HER2-positive breast cancer [J]. Journal of Practical Oncology, 2022, 36(5): 445-451.
[5]	LI Xiong, JIANG Wenkai, LANG Zekun, RUI Shaozhen. Research progress on the relationship between tumor-associated neutrophils and pancreatic cancer [J]. Journal of Practical Oncology, 2022, 36(5): 458-462.
[6]	GUO Ling, SU Yajuan. Research progress of peptide probe in tumor imaging [J]. Journal of Practical Oncology, 2022, 36(4): 360-363.
[7]	LI Bo, PENG Xiaolin, WANG Shanshan, LI Gairui, ZHAO Dan, PENG Ji. Comparative study on application effect of two risk assessment models in screening colorectal cancer [J]. Journal of Practical Oncology, 2022, 36(3): 197-202.
[8]	WANG Hongying, LI Yan, HAN Xinhao, WEI Xiaoli, JIA Huixun, YUAN Wenjuan, ZHANG Qiuju. Construction and validation of a risk model for early diagnosis and prognosis of gastric cancer based on immune-related lncRNAs [J]. Journal of Practical Oncology, 2022, 36(2): 119-126.
[9]	CHEN He, WANG Qiucheng, CHENG Wen. The application progress of automatic breast ultrasound diagnosis system in breast cancer [J]. Journal of Practical Oncology, 2022, 36(2): 193-196.
[10]	LIU Jinshuang, ZHAGN Wenjing, LI Qingwei, LI Zhiwei. Research progress of therapies combined immune checkpoint inhibitors in pancreatic cancer [J]. Journal of Practical Oncology, 2022, 36(1): 49-53.
[11]	ZHANG Wenjing, LIU Jinshuang, WANG Dan, LI Qingwei, LI Zhiwei. Research status of neoadjuvant therapy for pancreatic cancer [J]. Journal of Practical Oncology, 2022, 36(1): 64-68.
[12]	WANG Yang, LI Guodong, TANG Qingchao, LIU Ming. Research progress of acidosis in colorectal malignant tumors [J]. Journal of Practical Oncology, 2022, 36(1): 74-78.
[13]	LI Yujun, LIU Liyang, XIAO Juanjuan, XUE Hua. Prognostic stratification and treatment progress in elderly patients with newly diagnosed multiple myeloma [J]. Journal of Practical Oncology, 2022, 36(1): 84-88.
[14]	TUO Jiyu, ZHANG Xia, HE Xiaomei, JIANG Wenzhen, FENG Jueping, JIN Xia, ZHANG Min, WEI Shaozhong. Analysis of the screening results of the urban cancer early diagnosis and treatment project in Hubei province from 2018 to 2019 [J]. Journal of Practical Oncology, 2021, 35(4): 297-301.
[15]	LI Qingyu, YANG Lei, ZHANG Xi, LIU Shuo, LI Huichao, ZHANG Qian, CHENG Yangyang, JI Jiafu, WANG Ning. Discussion on the management of early diagnosis and treatment for cancer under the coronavirus disease(COVID-19) [J]. Journal of Practical Oncology, 2021, 35(4): 302-306.

Research progress in the early diagnosis and minimally invasive surgical treatment of elderly pancreatic cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments